Published in Exp Neurol on June 27, 2012
Human mesenchymal stem cells - current trends and future prospective. Biosci Rep (2015) 1.04
Clinical applications of mesenchymal stem cells in chronic diseases. Stem Cells Int (2014) 0.98
The nerve growth factor signaling and its potential as therapeutic target for glaucoma. Biomed Res Int (2014) 0.83
Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives. Exp Mol Med (2015) 0.83
Vascular damage: a persisting pathology common to Alzheimer's disease and traumatic brain injury. Med Hypotheses (2013) 0.83
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine (2015) 0.82
Adult human neural stem cell therapeutics: Current developmental status and prospect. World J Stem Cells (2015) 0.78
Postnatal age governs the extent of differentiation of hippocampal CA1 and CA3 subfield neural stem/progenitor cells into neurons and oligodendrocytes. Int J Dev Neurosci (2013) 0.78
Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cells. Neural Regen Res (2012) 0.77
Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain. Neurotherapeutics (2016) 0.75
History of Neural Stem Cell Research and Its Clinical Application. Neurol Med Chir (Tokyo) (2016) 0.75
Effects of brain-derived neurotrophic factor-pretreated neuron stem cell transplantation on Alzheimer's disease model mice. Int J Clin Exp Med (2015) 0.75
Treatment Efficacy of NGF Nanoparticles Combining Neural Stem Cell Transplantation on Alzheimer's Disease Model Rats. Med Sci Monit (2015) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
The cholinergic hypothesis of geriatric memory dysfunction. Science (1982) 6.84
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A (2003) 5.44
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain (2007) 3.68
Stem cells for the treatment of neurological disorders. Nature (2006) 3.66
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med (2005) 3.46
Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol (1998) 3.28
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A (2009) 2.96
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron (2006) 2.88
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci (1986) 2.33
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (1987) 2.33
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci (2003) 2.28
Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest (2005) 2.25
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A (2003) 2.02
Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res (2009) 1.95
Cell therapy in Parkinson's disease. NeuroRx (2004) 1.93
Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol (2005) 1.89
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature (1995) 1.79
The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci (2003) 1.71
Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology (2004) 1.67
Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci (2006) 1.59
Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke (2011) 1.58
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke (2000) 1.55
Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med (2007) 1.55
Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia (2005) 1.41
Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One (2007) 1.41
The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair (2009) 1.34
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci (1990) 1.17
Stem cells may reshape the prospect of Parkinson's disease therapy. Brain Res Mol Brain Res (2005) 1.16
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol (1992) 1.13
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol (1995) 1.13
Human neural stem cell tropism to metastatic breast cancer. Stem Cells (2012) 1.13
Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res (2010) 1.11
Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction. Exp Neurol (2012) 1.09
Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience (2005) 1.08
Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS One (2009) 1.05
Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther (2009) 1.04
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J Clin Invest (2006) 1.04
Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. Cell Transplant (2011) 1.04
Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med (1988) 1.02
Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS One (2009) 1.00
Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther (2007) 1.00
Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Lett (2011) 0.99
Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol (2002) 0.98
Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. Gene Ther (2009) 0.96
Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci (1993) 0.95
BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix. Neurosci Lett (2008) 0.94
Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma. Gene Ther (2012) 0.93
Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci U S A (2002) 0.92
Stem cell treatment for Parkinson's disease: an update for 2005. Curr Opin Neurol (2005) 0.90
Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction. Cell Transplant (2012) 0.90
Stem cells in the treatment of Parkinson's disease. Brain Res Bull (2002) 0.90
Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol (1994) 0.89
Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet (1989) 0.88
Neural transplantation for neurodegenerative disorders. Lancet (1999) 0.88
Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. Curr Stem Cell Res Ther (2010) 0.88
Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology (2008) 0.86
The promise of stem cells in Parkinson disease. J Clin Invest (2005) 0.84
Long-term functional restoration by neural progenitor cell transplantation in rat model of cognitive dysfunction: co-transplantation with olfactory ensheathing cells for neurotrophic factor support. Int J Dev Neurosci (2008) 0.83
Neural transplantation for treatment of Parkinson's disease. Drug Discov Today (2002) 0.82
Transplantation therapy for Parkinson's disease. Expert Opin Investig Drugs (2000) 0.77